Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study

Starting soon · Phase 3 · Has a placebo group

Conditions studied: Neurodevelopment Outcome, Linear Growth, Micronutrient Status, Bone Mineral Density, Underweight, Stunting, Body Composition, Blood Pressure, HRQOL (Health Related Quality Of Life), Waist-to-height Ratio

In brief

MEDHA is a randomized controlled trial among 10-18 year old girls to examine the use-case of the United Nations International Multiple Micronutrient Antenatal Preparation (UNIMMAP) multiple micronutrient supplement (MMS) formulation and to test an enhanced regimen (MMS+) with additional nutrients, vs. weekly iron-folic acid as standard of care on outcomes of neurodevelopment, linear growth, biochemical status, bone health, and other functional and health outcomes. This study is an individually randomized, open-label, three-arm trial of 3,000 participants supplemented for 12 months to assess the efficacy and safety of nutrient supplementation. Results of the study will inform the design of nutritional interventions and policy for this age group. In the context of the trial, the investigators will also do in-depth clinical and health assessments and collect biospecimens for a bio-archive for future deep-phenotyping of this population. This study will be conducted at the Johns Hopkins Bangladesh JiVitA field site in rural Gaibandha District of Bangladesh.

Key facts

Study ID
NCT07695883
Run by
Johns Hopkins Bloomberg School of Public Health
People needed
3000
Starts
2026-09-01
Expected to finish
2028-06-30
Last updated by the study team
2026-08-06

Who can join

Age: 10 and older, up to 18. Sex: female. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.